Checkpoint Therapeutics Inc (CKPT)
2.12
+0.07
(+3.41%)
USD |
NASDAQ |
Jun 14, 16:00
2.07
-0.05
(-2.36%)
After-Hours: 20:00
Checkpoint Therapeutics Net Income (Quarterly): -10.94M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -10.94M |
December 31, 2023 | -19.13M |
September 30, 2023 | -5.724M |
June 30, 2023 | -16.52M |
March 31, 2023 | -10.47M |
December 31, 2022 | -21.02M |
September 30, 2022 | -10.61M |
June 30, 2022 | -14.14M |
March 31, 2022 | -16.85M |
December 31, 2021 | -29.76M |
September 30, 2021 | -11.26M |
June 30, 2021 | -9.144M |
March 31, 2021 | -6.505M |
December 31, 2020 | -10.22M |
September 30, 2020 | -4.93M |
June 30, 2020 | -4.645M |
March 31, 2020 | -3.281M |
December 31, 2019 | -8.826M |
Date | Value |
---|---|
September 30, 2019 | -5.206M |
June 30, 2019 | -4.792M |
March 31, 2019 | -5.89M |
December 31, 2018 | -11.62M |
September 30, 2018 | -9.344M |
June 30, 2018 | -6.639M |
March 31, 2018 | -8.765M |
December 31, 2017 | -5.918M |
September 30, 2017 | -5.928M |
June 30, 2017 | -6.448M |
March 31, 2017 | -4.383M |
December 31, 2016 | -8.323M |
September 30, 2016 | -5.128M |
June 30, 2016 | -5.405M |
March 31, 2016 | -3.605M |
December 31, 2015 | -8.051M |
September 30, 2015 | -3.749M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-29.76M
Minimum
Dec 2021
-3.281M
Maximum
Mar 2020
-11.20M
Average
-10.35M
Median
Net Income (Quarterly) Benchmarks
QuidelOrtho Corp | -1.706B |
Fortress Biotech Inc | -15.42M |
Anavex Life Sciences Corp | -10.55M |
Ocugen Inc | -11.92M |
NovaBay Pharmaceuticals Inc | -3.214M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 10.95M |
EPS Diluted (Quarterly) | -0.33 |
Enterprise Value | 66.88M |
Earnings Yield | -130.7% |
Normalized Earnings Yield | -175.62 |